In a major development for patients and the biotechnology industry, the U.S. Food and Drug Administration approved the use of a new drug, Aduhelm (aducanumab), for treating early Alzheimer's disease. "This is the first time…

More than 50 infant deaths were linked to the sleeper, according to the report. June 7, 2021, 5:15 PM • 7 min read Share to FacebookShare to TwitterEmail this article Fisher-Price ignored repeated warnings that…